Factors | pT-stage | Surgical margin | Gleason score | Index tumor volume | Â | Â | Â | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ≤pT2 | ≥pT3 | p-value | neg | posi | p-value | ≤6 | ≥7 | p-value | <0.5 mL | ≥0.5 mL | p-value | <1.3 mL | ≥1.3 mL | p-value |
Prostate volume (cc) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≥35.5 | 81 | 4 | 0.0004 | 79 | 6 | 0.0009 | 61 | 24 | <0.0001 | 60 | 25 | <0.0001 | 71 | 14 | <0.0001 |
<35.5 | 64 | 21 | Â | 62 | 23 | Â | 32 | 53 | Â | 27 | 58 | Â | 46 | 39 | Â |
PSA density (ng/ml/cc) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
<0.172 | 78 | 7 | 0.0228 | 78 | 7 | 0.0037 | 58 | 27 | 0.0007 | 56 | 29 | 0.0002 | 69 | 16 | 0.0008 |
≥0.172 | 67 | 18 |  | 63 | 22 |  | 35 | 50 |  | 31 | 54 |  | 48 | 37 |  |
Tumor length (mm) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≤2.0 | 107 | 11 | 0.0045 | 102 | 16 | 0.0788 | 76 | 42 | 0.0002 | 74 | 44 | <0.0001 | 88 | 30 | 0.0194 |
>2.0 | 38 | 14 | Â | 39 | 13 | Â | 17 | 35 | Â | 13 | 39 | Â | 29 | 23 | Â |
MRI findings | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Positive | 99 | 14 | 0.2560 | 99 | 14 | 0.0305 | 69 | 44 | 0.0227 | 68 | 45 | 0.0011 | 83 | 30 | 0.0801 |
Negative | 46 | 11 | Â | 42 | 15 | Â | 24 | 33 | Â | 19 | 38 | Â | 34 | 23 | Â |
Epstein criteria | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 63 | 7 | 0.1880 | 65 | 5 | 0.0038 | 48 | 22 | 0.0029 | 49 | 21 | <0.0001 | 57 | 13 | 0.0040 |
No | 82 | 18 | Â | 76 | 24 | Â | 45 | 55 | Â | 38 | 63 | Â | 60 | 40 | Â |
PRIAS criteria | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 91 | 21 | 0.1870 | 90 | 13 | 0.0633 | 65 | 38 | 0.0075 | 64 | 39 | 0.0005 | 79 | 24 | 0.0070 |
No | 54 | 13 | Â | 51 | 16 | Â | 28 | 39 | Â | 23 | 44 | Â | 38 | 39 | Â |